Selling a practice is often the largest financial transaction of a physician’s career, and it is usually the first one they have ever done. The buyer, especially a private equity platform or a strategic acquirer, has done dozens. That asymmetry is where most seller-side mistakes come from. It is also part of a larger trend: according to the American Medical Association, the share of physicians in private practice continues to decline as more physicians join larger organizations, which means more doctors are facing these transactions for the first time. The errors are rarely dramatic. They are quiet decisions made early, under time pressure, that quietly narrow a physician’s options later.
Our firm recently closed a $9 million physician practice sale built on a tax-efficient F reorganization, rollover equity into the parent company, and an ongoing Management Services Agreement. That kind of structure can serve a physician well, but only when every moving part is understood before signing. The same mechanisms that create value in a well-run deal, rollover, earnouts, MSA terms, are exactly where we see physicians get hurt when they are rushed or unrepresented. Below are the mistakes we see most often, and how to avoid them.
Mistake 1: Signing the letter of intent too quickly
The letter of intent feels preliminary. It is usually labeled non-binding. So physicians sign it fast, eager to show good faith and move the deal along. This is the single most consequential mistake in the process, because the LOI is where your leverage peaks and then begins to fall. Even general guidance bears this out: the U.S. Small Business Administration recommends organizing financial records and planning well in advance before taking any business to market, and a physician practice sale layers regulatory, compensation, and tail-coverage issues on top of that baseline.
Once you sign, you are typically bound by an exclusivity provision that stops you from talking to other buyers for 60, 90, or 120 days. From that moment, the buyer knows you have nowhere else to go. Price, structure, working capital treatment, earnout terms, and employment framework are all far easier to shape before the LOI than after it. An LOI that is vague on those points is not a convenience to be cleaned up later; it is a set of open questions the buyer will resolve in its own favor during drafting.
The deeper problem is that the LOI quietly settles more than most physicians realize. Terms that feel like details at signing, the tax structure, the non-compete, how the price is split between cash and rollover, often turn out to be the terms that matter most, and they are hard to reopen once they are on paper.
For the details of what belongs in an LOI and what to resist, see our forthcoming guide on the medical practice letter of intent.
Mistake 2: Treating rollover equity as guaranteed money
In most private equity practice deals, you do not walk away with all cash. A portion of your proceeds is “rolled over” into equity in the buyer’s parent company, the so-called second bite of the apple. Physicians frequently treat that rollover figure as if it were cash in the bank. It is not.
Rollover equity is an investment, with the risks of an investment. Its value depends on the platform’s future performance, the terms attached to your equity class, and whether a second sale actually happens on the timeline everyone assumes. It can be diluted by later capital raises. It may sit behind the PE sponsor’s preferred return, meaning the sponsor gets paid first if the second exit underperforms. A deal that looks like $9 million on paper may deliver a very different number if a large slice of it is rollover that later softens.
This does not make rollover bad. In a strong platform it can be the most lucrative part of the deal. But it should be evaluated as equity, with attention to the class of units, dilution protection, and what happens to your stake if you leave or are terminated after closing.
Mistake 3: Ignoring the employment agreement you sign after closing
Here is the part that surprises physicians most: after you sell, you usually become an employee of the entity you just sold to. The purchase price gets all the attention, but the employment agreement you sign at closing governs your daily life for years afterward, and it is frequently far less favorable than the one you had as an owner.
Compensation often resets to a productivity model you did not design. A new, broad non-compete can attach, one that follows you across every location the platform owns or later acquires. Call obligations, termination rights, and tail coverage responsibility all get rewritten. We have seen physicians negotiate hard on purchase price and pay almost no attention to the employment terms, only to find their post-sale income and mobility materially worse than expected.
The employment agreement is not a side document. It is part of the price. A slightly higher headline number paired with a punishing compensation reset and a market-wide non-compete can be a worse deal than a lower number with fair employment terms. This is where the seller-side transaction connects directly to everything we write about on the employment side, including the physician non-compete clause, the broader restrictive covenant, and who pays tail coverage.
Mistake 4: Underestimating the earnout
When buyer and seller cannot agree on value, they often bridge the gap with an earnout: part of the price is deferred and paid only if the practice hits defined targets after closing. Earnouts sound fair. In practice, they usually favor the buyer, because the buyer controls the business during the earnout period.
Once you no longer control operations, the levers that determine whether you hit your targets, staffing, billing, payer contracts, marketing, even how revenue is attributed, may be in someone else’s hands. Physicians routinely accept aggressive earnout targets they would never have agreed to if they had modeled the downside. The right questions are: what exactly is measured, who controls the inputs, what happens if the buyer changes operations, and what is your recourse if the target is missed for reasons outside your control.
Mistake 5: Misreading how deal structure drives taxes
Two deals at the same price can leave very different amounts in your pocket after tax. Whether the transaction is an asset sale or a stock sale, how the purchase price is allocated across asset classes, whether an F reorganization or similar structure is used, and how rollover is treated all change the tax outcome, sometimes dramatically.
Physicians often treat structure as the lawyers’ and accountants’ problem and focus only on the gross number. But structure is not a technicality; it is a major determinant of your net proceeds. The $9 million transaction we structured used an F reorganization specifically because the structure carried real tax efficiency for the seller. That kind of planning has to happen before the deal terms are set, not after. This is genuinely a coordinate-with-your-CPA area, and the earlier the tax advisor is in the room, the better.
Mistake 6: Not understanding who actually controls the practice after the sale
In most private equity healthcare deals, the structure separates the clinical entity from the business operations, often through a Management Services Organization and a Management Services Agreement. The physician may keep nominal ownership of the professional corporation while the MSO controls the business side under a long-term management agreement.
Physicians sometimes sign these arrangements without fully grasping how much operational control shifts to the MSO, over staffing, scheduling, vendor decisions, billing, and the economics of the practice. Understanding the MSO and MSA structure, and what you are truly retaining versus giving up, is central to evaluating any PE offer. We cover this in depth in our guides on the MSO structure and the corporate practice of medicine doctrine.
Mistake 7: Going without physician-side representation
The buyer has experienced M&A counsel, a tax team, and a deal team that runs transactions like this for a living. A physician who relies on a generalist attorney, or no attorney until late, is negotiating from a structural disadvantage. This is not about distrust; it is about experience parity.
Physician-side representation means someone whose job is your side of the table, who understands not just contract law but physician compensation models, healthcare regulatory constraints, and the career implications of the terms. The cost of that representation is almost always small relative to the size of the transaction and the value of the terms it protects.
How these mistakes compound
The reason these errors are so costly is that they interact. A rushed LOI locks in a weak structure. A weak structure worsens the tax outcome. An overlooked employment agreement compounds a soft rollover. An aggressive earnout paired with loss of operational control turns deferred “price” into money you may never see. No single mistake sinks a deal on its own; together, they can turn an impressive headline number into a disappointing real one.
| Mistake | Where it shows up | The fix |
|---|---|---|
| Signing the LOI too fast | Start of the deal | Negotiate key terms before exclusivity attaches |
| Rollover treated as cash | Price discussion | Evaluate rollover as an at-risk investment |
| Ignoring the employment agreement | Closing documents | Treat employment terms as part of the price |
| Underestimating the earnout | Purchase agreement | Model the downside; check who controls the inputs |
| Misreading tax structure | Deal structuring | Bring in legal and tax advisors before terms lock |
| Missing the MSO control shift | MSA / governance | Map what you retain vs. give up operationally |
Selling a practice can be an excellent outcome. The physicians who do best are not the ones who negotiate hardest on price; they are the ones who understand the whole transaction, structure, employment, tax, and control, before they sign anything. You can browse more physician legal resources and guides to prepare.
About Med Contract Law. Med Contract Law represents physicians and physician-owned practices in the transactions that shape a career — practice sales to private equity and strategic buyers, MSO and management services arrangements, employment and compensation agreements, and partnership buy-ins and buyouts. Our focus is the physician’s side of the table: protecting your autonomy, your compensation, and the long-term value of what you have built.
Selling a medical practice is often the largest financial transaction of a physician’s career. Whether you are evaluating an unsolicited offer, negotiating with a private equity-backed platform, or planning a long-term succession, experienced physician-side counsel can help protect your interests at every stage. Schedule a confidential consultation to talk through your situation.
Frequently asked questions
What is the most common mistake physicians make when selling a practice? Signing the letter of intent too quickly. The LOI is where your leverage is highest, and once you sign an exclusivity provision, the buyer knows you cannot shop the deal — which shifts negotiating power on price, structure, and employment terms toward the buyer.
Is rollover equity the same as cash in a practice sale? No. Rollover equity is an at-risk investment in the buyer’s parent company. Its value depends on future performance, your equity class, dilution, and whether a second sale happens as expected. It should be evaluated separately from the cash portion, not added to it as if both were guaranteed.
Why does the employment agreement matter if I’m selling my practice? Because after most sales you become an employee of the buyer. That agreement governs your compensation, non-compete, call, termination rights, and tail coverage for years after closing. Unfavorable employment terms can outweigh a strong headline price.
Are earnouts good or bad for physician sellers? It depends on the terms. Earnouts defer part of the price until post-closing targets are met, but the buyer usually controls operations during that period. Model the downside and confirm what is measured, who controls the inputs, and your recourse if targets are missed for reasons outside your control.
Does how the deal is structured really affect my taxes? Yes, significantly. Asset vs. stock sale, price allocation, use of an F reorganization, and rollover treatment can all change your net proceeds. Structure should be planned with legal and tax advisors before terms are locked, not treated as an afterthought.
Do I really need a physician-side attorney to sell my practice? For a transaction of this size and complexity, it is strongly advisable. The buyer has experienced M&A counsel and a tax team. Physician-side representation gives you experience parity and someone focused on your side of the structure, employment, and regulatory issues.